KKPCF (Kaken Pharmaceutical Co) Common Stock: $150.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KKPCF Kaken Pharmaceutical Co Ltd KKPCF
69 GF Score
Price $26.00
GF Value $25.42
! 2 Warning Signs
View Full Analysis

What is Kaken Pharmaceutical Co Common Stock?

Kaken Pharmaceutical Co KKPCF 69 Common Stock is $150.3 Mil as of Mar. 2026. GuruFocus rates KKPCF with a GF Score™ of 69/100 and a GF Value™ of $25.42. The stock has 2 warning signs investors should review.

Kaken Pharmaceutical Co's quarterly common stock declined from Sep. 2025 ($161.3 Mil) to Dec. 2025 ($153.0 Mil) and declined from Dec. 2025 ($153.0 Mil) to Mar. 2026 ($150.3 Mil).

Kaken Pharmaceutical Co's annual common stock increased from Mar. 2024 ($159.2 Mil) to Mar. 2025 ($160.0 Mil) but then declined from Mar. 2025 ($160.0 Mil) to Mar. 2026 ($150.3 Mil).

Kaken Pharmaceutical Co Common Stock Historical Data

* Premium members only.

The historical data trend for Kaken Pharmaceutical Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaken Pharmaceutical Co Common Stock Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 201.16 178.46 159.21 160.03 150.32

Kaken Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 160.03 165.09 161.32 152.99 150.32
KKPCF
69GF Score
Kaken Pharmaceutical Co Ltd KKPCF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kaken Pharmaceutical Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $150.3 Mil mean?
Kaken Pharmaceutical Co (KKPCF) has a Common Stock of $150.3 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kaken Pharmaceutical Co and its competitors.
Is Kaken Pharmaceutical Co's Common Stock too high?
Kaken Pharmaceutical Co's current Common Stock is $150.3 Mil. Overall, Kaken Pharmaceutical Co has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Kaken Pharmaceutical Co's Common Stock compare to ZTS and UTHR?
Kaken Pharmaceutical Co's Common Stock of $150.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kaken Pharmaceutical Co and its competitors. Kaken Pharmaceutical Co's current Common Stock is $150.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaken Pharmaceutical Co stock overvalued right now?
Kaken Pharmaceutical Co (KKPCF) has a current Common Stock of $150.3 Mil. The stock's GF Value™ is $25.42, compared to a current price of $26.00 — trading 2.3% above its estimated fair value. The current Common Stock is $150.3 Mil. Kaken Pharmaceutical Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Kaken Pharmaceutical Co (KKPCF), the current Common Stock is $150.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kaken Pharmaceutical Co (KKPCF) Overvalued in 2026?

Based on GuruFocus' analysis, Kaken Pharmaceutical Co stock appears to be overvalued. The current stock price of $26.00 is trading 2.3% above its estimated GF Value™ of $25.42.

Key valuation signals for KKPCF:

  • Common Stock: $150.3 Mil
  • GF Value™: $25.42 vs. price of $26.00 (2.3% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the KKPCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kaken Pharmaceutical Co Business Description

Other Exchanges 4521:Japan
Address 28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
69GF Score

Get the complete analysis for KKPCF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.00
Price
$25.42
GF Value